题名

Apoptotic Effects of Over-Expressed Estrogen Receptor-β on LoVo Colon Cancer Cell is Mediated by p53 Signalings in a Ligand-Dependent Manner

作者

Hsi-Hsien Hsu；Sue-Fei Cheng；Cheng-Chung Wu；Chun-Hsien Chu；Yi-Jiun Weng；Chung-Sheng Lin；Shin-Da Lee；Hung-Chien Wu；Chih-Yang Huang；Wei-Wen Kuo

关键词

estrogen receptor-β ； LoVo cells ； apoptotic effects ； antiproliferation

期刊名称

The Chinese Journal of Physiology

卷期/出版年月

49卷2期（2006 / 04 / 01）

页次

110 - 116

内容语文

英文
英文摘要

Epidemiologic studies reported that the prevalence of hereditary non-polyposis colon cancer (HNPCC) in male is about 1.5-fold higher than that in female. Decreases in circulatory estradiol (E2) have been reported to downregulate the expression of E2 receptor (ER) and significantly increase the risk of colorectal cancer. Patients that received E2 replacement therapy were found to have a reduction in the incidence of colon adenoma and carcinoma. Furthermore, significant decreases in the expression of ER have been found in colorectal cancer specimens. These data strongly suggest the protective roles of E2 and ER against colorectal cancer. However, the mechanisms remain unexplored. LoVo cells were transient transfected to overexpress ER-β, DNA fragmentation and caspase activity assay were performed to evaluate apoptotic effects. Western blotting was used to evaluate protein levels, and luciferase activity assay to measure the TNF-α promoter activity. Our data clearly demonstrated that E2 and ER-β alone could upregulate p21 and p27 proteins, which further activate caspase-8 and caspase-9 to induce apoptosis in LoVo cell, and the ER-β effects were enhanced by E2. However, overexpressed ER-β did not influence the expression and promoter activity of TNF-α. In addition, E2 and overexpressed ER-β downregulated the β-catenin proteins which cause the downregulation of its target genes, cyclin D1 and Rb, to inhibit the cell cycle and cell proliferation. The results indicate that overexpressed ER-β may induce LoVo cell apoptosis and anti-proliferation by increasing p53 signaling in a ligand-dependent manner, and without hTNF-α involvement. Efforts aiming at enhancing ER-β expression and/or activity may prove to be an attractive alternative therapy against colorectal cancer.
主题分类 醫藥衛生 > 基礎醫學
参考文献
  1. Arts, J.,Kuiper, G.G.,Janssen, J.M.,Gustafsson, J.A.,Lowik, C.W.,Pols, H.A.,van Leeuwen, J.P.(1997).Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells.Endocrinology,138,5067-5070.
  2. Cadigan, K.M.,Nusse, R.(1997).Wnt signaling: a common theme in animal development..Genes Dev.,11,3286-3305.
  3. Campbell-Thompson, M.,Lynch, I.J.,Bhardwaj, B.(2001).Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.Cancer Res.,61,632-640.
  4. Christofori, G.(2003).Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumour progression..EMBO J.,22,2318-2323.
  5. Crawford, H.C.,Fingleton, B.M.,Rudolph-Owen, L.A.,Heppner Goss, K.J.,Rubinfeld, B.,Polakis, P.,Matrisian, L.M.(1999).The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors.Oncogene,18,2883-2891.
  6. Fodde, R.(2002).The APC gene in colorectal cancer..Eur. J. Cancer,38,867-871.
  7. Foley, E.F.,Jazaeri, A.A.,Shupnik, M.A.,Jazaeri, O.,Rice, L.W.(2000).Selective loss of estrogen receptor beta in malignant human colon..Cancer Res.,60,245-248.
  8. Fujimori, T.,Kawamata, H.,Kashida, H.(2001).Precancerous lesions of the colorectum.J. Gastroenterol,36,587-594.
  9. Greenlee, R.T.,Murray, T.,Bolden, S.,Wingo, P.A.(2000).Cancer statistics, 2000..Ca: a Cancer J. Clin.,50,7-33.
  10. Gustafsson, J.A.(1999).Estrogen receptor beta - a new dimension in estrogen mechanism of action.J. Endocrinol.,163,379-383.
  11. He, T.C.,Sparks, A.B.,Rago, C.,Hermeking, H.,Zawel, L.,da Costa, L.T.,Morin, P.J.,Vogelstein, B.,Kinzler, K.W.(1998).Identification of c-Myc as a target of the APC pathway..Science,281,1509-1512.
  12. Herrmann, M.,Lorejz, H.M.,Voll, R.,Grunke, M.,Woith, W.,Kalden, J.R.(1994).A rapid and simple method for the isolation of apoptotic DNA fragments..Nucleic Acids Res.,22,5506-5507.
  13. Holland, T.A.,Elder, J.,McCloud, J.M.,Hall, C.,Deakin, M.,Fryer, A.A.,Elder, J.B.,Hoban, P.R.(2001).Subcellular localization of cyclin D1 protein in colorectal tumours is associated with p21 (WAF1/CIP1) expression and correlates with patient survival..Int. J. Cancer,95,302-306.
  14. Horvath, L.G.,Henshall, S.M.,Lee, C.S.,Head, D.R.,Quinn, D.I.,Makela, S.,Delprado, W.,Golovsky, D.,Brenner, P.C.,O'Neill, G.,Kooner, R.,Stricker, P.D.,Grygiel, J.J.,Gustafsson, J.A.,Sutherland, R.L.(2001).Frequent loss of estrogen receptor-beta expression in prostate cancer..Cancer Res.,61,5331-5335.
  15. Houlston, R.S.(2001).What we could do now: molecular pathology of colorectal cancer..Mol. Pathol.,54,206-214.
  16. Jamora, C.,Fuchs, E.(2002).Intercellular adhesion, signalling and the cytoskeleton.Nature Cell Biol.,4,101-108.
  17. Kampman, E.,Potter, J.D.,Slattery, M.L.,Caan, B.J.,Edwards, S.(1997).Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United States.Cancer Causes Control,8,146-158.
  18. Kim, D.M.,Koo, S.Y.,Jeon, K.,Kim, M.H.,Lee, J.,Hong, C.Y.,Jeong, S.W.(2003).Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor (TNF)-α or TNF-related apoptosis-inducing ligand in human cancer cell lines.Cancer Res,63,621-626.
  19. Konstantinopoulos, P.A.,Kominea, A.,Vandoros, G.,Sykiotis, G.P.,Andricopoulos, P.,Varakis, I.,Sotiropoulou-Bonikou, G.,Papavassiliou, A.G.(2003).Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation.Eur. J. Cancer,39,1251-1258.
  20. Kuiper, G.G.,Carlsson, B.,Grandien, K.,Enmark, E.,Haggblad, J.,Nilsson, S.,Gustafsson, J.A.(1997).Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta.Endocrinology,138,863-870.
  21. Kuzumaki, T.,Kobayashi, T.,Ishikawa, K.(1998).Genistein induces p21(Cip1/WAF1) expression and blocks the G1 to S phase transition in mouse fibroblast and melanoma cells.Biochem. Biophys. Res. Commun.,251,291-295.
  22. Liedtke, C.,Groger, N.,Manns, M.P.,Trautwein, C.(2003).The human caspase-8 promoter sustains basal activity through SP1 and ETSlike transcription factors and can be up-regulated by a p53-dependent Mechanism.J. Biol. Chem.,278,27593-27604.
  23. Liu, M.M.,Albanese, C.,Anderson, C.M.,Hilty, K.,Webb, P.,Uht, R.M.,Price, R.H.,Pestell, R.G.,Kushner, P.J.(2002).Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression.J. Biol. Chem.,277,24353-24360.
  24. Lu, B.,Leygue, E.,Dotzlaw, H.,Murphy, L.J.,Murphy, L.C.,Watson, P.H.(1998).Estrogen receptor-beta mRNA variants in human and murine tissues..Mol. Cell. Biol.,138,199-203.
  25. Mann, B.,Gelos, M.,Siedow, A.,Hanski, M.L.,Gratchev, A.,Ilyas, M.,Bodmer, W.F.,Moyer, M.P.,Riecken, E.O.,Buhr, H.J.,Hanski, C.(1999).Target genes of beta-catenin-T-cell-factor/lymphoidenhancer factor signaling in human colorectal carcinomas.Proc. Natl. Acad. Sci. USA,96,1603-1608.
  26. Martin, S.J.,Green, D.R.(1995).Protease activation during apoptosis: death by a thousand cuts?.Cell,82,349-352.
  27. Matsuzawa, S.I.,Reed, J.C.(2001).Siah-1, SIP, and Ebi collaborate in a novel pathway for β-catenin degradation linked to p53 responses.Mol. Cell.,7,915-926.
  28. Muramatsu, M.,Inoue, S.(2000).Estrogen receptors: how do they control reproductive and nonreproductive functions?.Biochem. Biophys. Res. Commun,270,1-10.
  29. Murphy, L.C.,Dotzlaw, H.,Leygue, E.,Douglas, D.,Coutts, A.,Watson, P.H.(1997).Estrogen receptor variants and mutations..J. Steroid Biochem. Mol. Biol.,62,363-372.
  30. Nicholson, D.W.,Thornberry, N.A.(1997).Caspases: killer proteases.Trends Biochem. Sci.,22,299-306.
  31. Nilsen, J.,Mor, G.,Naftolin, F.(2000).Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system.J. Neurobiol.,43,64-78.
  32. Pagliarini, R.A.,Xu, T.(2003).A genetic screen in Drosophila for metastatic behavior.Science,302,1227-1231.
  33. Palmqvist, R.,Stenling, R.,Oberg, A.,Landberg, G.(1998).Expression of cyclin D1 and retinoblastoma protein in colorectal cancer.Eur. J. Cancer,34,1575-1581.
  34. Park, J.H.,Oh, E.J.,Choi, Y.H.,Kang, C.D.,Kang, H.S.,Kim, D.K.,Kang, K.I.,Yoo, M.A.(2001).Synergistic effects of dexamethasone and genistein on the expression of Cdk inhibitor p21WAF1/CIP1 in human hepatocellular and colorectal carcinoma cells.Int. J. Oncol.,18,997-1002.
  35. Pisani, P.,Parkin, D.M.,Bray, F.,Ferlay, J.(1999).Estimates of the worldwide mortality from 25 cancers in 1990..Int. J. Cancer,83,18-29.
  36. Polakis, P.(2000).Wnt signaling and cancer..Genes Dev.,14,1837-1851.
  37. Roger, P.,Sahla, M.E.,Makela, S.,Gustafsson, J.A.,Baldet, P.,Rochefort, H.(2001).Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors.Cancer Res.,61,2537-2541.
  38. Schulte-Hermann, R.,Bursch, W.,Low-Baselli, A.,Wagner, A.,Grasl-Kraupp, B.(1997).Apoptosis in liver and its role in hepatocarcinogenesis..Cell. Biol. Toxicol.,13,339-348.
  39. Tetsu, O.,McCormick, F.(1999).Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.Nature,398,422-426.
  40. Thiery, J.P.(2002).Epithelial-mesenchymal transitions in tumour progression..Nature Rev. Cancer,2,422-454.
  41. Ueno, Y.,Moriyama, M.,Uchida, T.,Arakawa, Y.(2001).Irregular regeneration of hepatocytes is an important factor in the hepatocarcinogenesis of liver disease.Hepatology,33,357-362.
  42. Vaculova, A.,Hofmanova, J.,Soucek, K.,Kovarikova, M.,Kozubik, A.(2002).Tumor necrosis factor-alpha induces apoptosis associated with poly(ADP-ribose) polymerase cleavage in HT-29 colon cancer cells..Anticancer Res.,22,1635-1639.
  43. Wingo, P.A.,Ries, L.A.,Rosenberg, H.M.,Miller, D.S.,Edwards, B.K.(1998).Cancer incidence and mortality, 1973-1995: a report card for the U.S..Cancer,82,1197-1207.
  44. Wu, G.S.,Ding, Z.(2002).Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line.Oncogene,21,1-8.
  45. Yang, J.,Liu, A.,Chiou, S.K.,Guzman, R.,Nandi, S.(2000).Estrogen receptor variants are present in many normal human tissues.Int. J. Mol. Med.,5,223-227.
  46. Zimmermann, K.C.,Bonzon, C.,Green, D.R.(2001).The machinery of programmed cell death.Pharmacol. Therap.,92,57-70.
print cancel